Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort
- PMID: 22792293
- PMCID: PMC3391259
- DOI: 10.1371/journal.pone.0040374
Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort
Abstract
Introduction: In experimental models of West Nile virus (WNV) infection, animals develop chronic kidney infection with histopathological changes in the kidney up to 8-months post-infection. However, the long term pathologic effects of acute infection in humans are largely unknown. The purpose of this study was to assess renal outcomes following WNV infection, specifically the development of chronic kidney disease (CKD).
Methods: In a cohort of 139 study participants with a previous diagnosis of WNV infection, we investigated the prevalence of CKD using the Kidney Disease Outcomes Quality Initiative (KDOQI) criteria based on the Modification of Diet in Renal Disease (MDRD) formula and urinary abnormalities, and assessed various risk factors and biomarkers.
Results: Study participants were primarily male (60%) and non-Hispanic white (86%) with a mean age of 57 years. Most (83%) were four to nine years post-infection at the time of this study. Based on the KDOQI definition, 40% of participants had evidence of CKD, with 10% having Stage III or greater and 30% having Stage I-II. By urinary dipstick testing, 26% of patients had proteinuria and 23% had hematuria. Plasma NGAL levels were elevated in 14% of participants while MCP-1 levels were increased in 12%. Over 1.5 years, the average change in eGFR was -3.71 mL/min/1.73 m(2). Only a history of Neuroinvasive WNV disease was independently associated with CKD following multivariate analysis.
Discussion: We found a high prevalence of CKD after long term follow-up in a cohort of participants previously infected with WNV. The majority of those with CKD are in Stage I-II indicating early stages of renal disease. Traditional risk factors were not associated with the presence of CKD in this population. Therefore, clinicians should regularly evaluate all patients with a history of WNV for evidence of CKD.
Conflict of interest statement
Figures
Similar articles
-
Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.Kidney Int. 2013 May;83(5):909-14. doi: 10.1038/ki.2012.458. Epub 2013 Jan 23. Kidney Int. 2013. PMID: 23344473 Free PMC article.
-
Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586. Epub 2013 Jan 16. Nephrol Dial Transplant. 2013. PMID: 23328709
-
Unique Cytokine Response in West Nile Virus Patients Who Developed Chronic Kidney Disease: A Prospective Cohort Study.Viruses. 2021 Feb 17;13(2):311. doi: 10.3390/v13020311. Viruses. 2021. PMID: 33671257 Free PMC article.
-
West Nile virus and kidney disease.Expert Rev Anti Infect Ther. 2013 May;11(5):479-87. doi: 10.1586/eri.13.34. Expert Rev Anti Infect Ther. 2013. PMID: 23627854 Review.
-
Persistence of West Nile virus.Microbes Infect. 2015 Feb;17(2):163-8. doi: 10.1016/j.micinf.2014.12.003. Epub 2014 Dec 11. Microbes Infect. 2015. PMID: 25499188 Review.
Cited by
-
Visualization of West Nile Virus in Urine Sediment using Electron Microscopy and Immunogold up to Nine Years Postinfection.Am J Trop Med Hyg. 2017 Dec;97(6):1913-1919. doi: 10.4269/ajtmh.17-0405. Epub 2017 Oct 19. Am J Trop Med Hyg. 2017. PMID: 29141749 Free PMC article.
-
Current trends in West Nile virus vaccine development.Expert Rev Vaccines. 2014 May;13(5):589-608. doi: 10.1586/14760584.2014.906309. Epub 2014 Apr 1. Expert Rev Vaccines. 2014. PMID: 24689659 Free PMC article. Review.
-
Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus.J Neuroinflammation. 2014 Apr 21;11:80. doi: 10.1186/1742-2094-11-80. J Neuroinflammation. 2014. PMID: 24750819 Free PMC article.
-
The Neurocognitive and MRI Outcomes of West Nile Virus Infection: Preliminary Analysis Using an External Control Group.Front Neurol. 2018 Mar 27;9:111. doi: 10.3389/fneur.2018.00111. eCollection 2018. Front Neurol. 2018. PMID: 29636722 Free PMC article.
-
Wildlife Pathology Studies and How They Can Inform Public Health.ILAR J. 2016;56(3):306-11. doi: 10.1093/ilar/ilv043. ILAR J. 2016. PMID: 26912717 Free PMC article.
References
-
- Lindsey NP, Staples JE, Lehman JA, Fischer M. Surveillance for human West Nile virus disease–United States, 1999–2008. Morb Mort Weekly Report. 2010;59:1–17. - PubMed
-
- Tesh RB, Siirin M, Guzman H, Travassos da Rosa APA, Wu X, et al. Persistent west nile virus infection in the gold hamster: Studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis. 2010;192:287–295. - PubMed
-
- Baty SA, Gibney KB, Staples JE, Patterson AB, Levy C, et al. Evaluation for West Nile Virus (WNV) RNA in Urine of Patients Within 5 Months of WNV Infection. J Infect. 2012;Dis205(9):1476–1477. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous